Richard K Sterling
Overview
Explore the profile of Richard K Sterling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
236
Citations
8080
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang R, Ramalingam G, Hang Y, Spengler J, Smirnova E, Sterling R
Clin Gastroenterol Hepatol
. 2025 Mar;
PMID: 40081636
No abstract available.
2.
Liu H, Kim E, Wang Z, Nguyen T, Shieh F, Liu Y, et al.
medRxiv
. 2025 Feb;
PMID: 39974020
Background And Aims: Hepatitis B virus (HBV) generates a double-stranded linear DNA (dslDNA) byproduct during replication. This dslDNA can undergo intermolecular and intramolecular nonhomologous end-joining (NHEJ) recombination, resulting in viral...
3.
Parajuli P, Phipps L, Sabo R, Alsaadawi R, Robinson A, French E, et al.
J Clin Transl Sci
. 2025 Feb;
9(1):e22.
PMID: 39911936
Introduction: The respiratory syndrome coronavirus (SARS-CoV-2) has undergone genetic evolution and led to variants of concern that vary in transmissibility and clinical severity. Methods: This retrospective cohort analysis studied 232,364...
4.
Taddese M, Grudda T, Belluccini G, Anderson M, Cloherty G, Hwang H, et al.
J Clin Invest
. 2025 Feb;
PMID: 39898797
The cornerstone of functional cure for chronic hepatitis B (CHB) is hepatitis B surface antigen (HBsAg) loss from blood. HBsAg is encoded by covalently closed circular DNA (cccDNA) and HBV...
5.
Bajaj J, Fagan A, Gavis E, Sterling R, Gallagher M, Lee H, et al.
J Hepatol
. 2025 Jan;
PMID: 39800192
Background: Preventing hepatic encephalopathy (HE) recurrence in cirrhosis, which is associated with an altered gut-liver-brain axis, is an unmet need. Fecal microbiota transplantation (FMT) is beneficial in phase-1 studies, but...
6.
Price J, Hirose K, Chalasani N, Crandall H, Heath S, Loomba R, et al.
J Assoc Nurses AIDS Care
. 2024 Dec;
36(2):177-182.
PMID: 39718369
Nonalcoholic fatty liver disease (NAFLD) is highly prevalent in people with HIV (PWH) and increases the risk of hepatic fibrosis and hepatocellular carcinoma. We sent an online survey to providers...
7.
Epstein R, Munroe S, Taylor L, Duryea P, Buzzee B, Pramanick T, et al.
Clin Infect Dis
. 2024 Nov;
80(2):300-313.
PMID: 39535186
Background: Liver disease assessment is a key aspect of chronic hepatitis C virus (HCV) infection pre-treatment evaluation but guidelines differ on the optimal testing modality given trade-offs in availability and...
8.
Sterling R
Gastroenterol Hepatol (N Y)
. 2024 Nov;
20(9):554-556.
PMID: 39483997
No abstract available.
9.
Allende D, Cummings O, Sternberg A, Behling C, Carpenter D, Gill R, et al.
Aliment Pharmacol Ther
. 2024 Sep;
60(10):1351-1360.
PMID: 39238213
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is common in people with HIV (PWH). The morphological spectrum of MASLD compared to matched controls and of the correlation between the NAFLD...
10.
Silvey S, Patel N, Tsai S, Nadeem M, Sterling R, Markley J, et al.
Am J Gastroenterol
. 2024 Sep;
PMID: 39235290
Introduction: Spontaneous bacterial peritonitis (SBP) bacteriology has changed over time. Reappraisal of primary SBP prophylaxis showed an increased rate of resistance in patients on primary prophylaxis with resultant discontinuation of...